EUVIMEDEUVIMED entdecken
Crossref

Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series

Paolo Conca, Ernesto Cimino, Anna Guida, Rosa Albisinni, Tommaso Marrazzo, Raffaele Russo, Lucia Agrelli, Umberto Mazzarelli, Matteo Di Minno, Antonella Tufano

Seminars in Thrombosis and Hemostasis · 09.01.2026

DOI: 10.1055/a-2779-4843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 09.01.2026. Verfasst von Paolo Conca und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital factor VII (FVII) deficiency is the most common rare hemorrhagic disorder. Acquired FVII deficiency can be isolated or associated with other low coagulation factor levels. FVII levels do not accurately predict a patient's bleeding risk. In the case of surgery, the perioperative management needs to be evaluated on a case-by-case basis, considering the patient's bleeding history and the type of surgery. We present 12 patients with congenital or acquired FVII deficiency and describe the perioperative management with plasma-derived nonactivated FVII (pd-FVII) concentrate. Patients with factor VII deficiency treated with pd-FVII for perioperative hemostasis, between April 2022 and May 2025. We report thirteen procedures in 12 patients (11 males and 1 female; age range: 15–78 years). Two patients were affected by acquired deficiency, and 10 patients presented congenital deficiency. Perioperative prophylaxis with pd-FVII was performed at doses ranging from 20 to 40 IU/kg/dose. Total pd-FVII consumption ranged between 20 and 320 IU/kg. During and after surgery, there were no major bleeding or thrombotic events. In the postoperative period, only one patient presented with hematuria.

Autor:innen und Institutionen

  • Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
  • Centro per le Malattie Emorragiche Congenite e Malattie Trombotiche, AOU S. Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
  • UOC CCH Generale e dei Trapianti, AORN DEI COLLI OSP, Monaldi, Naples, Italy.
  • UOC Medicina Interna e dei Trapianti, AORN DEI COLLI OSP, Monaldi, Naples, Italy.

Zitieren

APA

Conca, P., Cimino, E., Guida, A., Albisinni, R., Marrazzo, T., Russo, R., Agrelli, L., Mazzarelli, U., Di Minno, M., & Tufano, A. (2026). Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2779-4843

Vancouver

Conca P, Cimino E, Guida A, Albisinni R, Marrazzo T, Russo R, et al. Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series. Seminars in Thrombosis and Hemostasis. 2026. doi:10.1055/a-2779-4843

BibTeX
@article{Conca2026,
  author = {Conca, Paolo and Cimino, Ernesto and Guida, Anna and Albisinni, Rosa and Marrazzo, Tommaso and Russo, Raffaele and Agrelli, Lucia and Mazzarelli, Umberto and Di Minno, Matteo and Tufano, Antonella},
  title = {Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2026},
  doi = {10.1055/a-2779-4843}
}
Kostenlos starten →